home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

299 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2025 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

  • Other 291
  • Notice 8

posted_year 1

  • 2025 · 299 ✖

agency_id 1

  • FDA 299
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-2421 FDA None FDA-2007-D-0369 PSG_208564 Draft Guidance on Estradiol Other Guidance 2025-12-16T05:00:00Z 2025 12 2025-12-16T05:00:00Z   2025-12-16T20:30:49Z   1 0 09000064b90dccd3
FDA-2007-D-0369-2420 FDA None FDA-2007-D-0369 PSG_020908 Draft Guidance on Estradiol Other Guidance 2025-12-16T05:00:00Z 2025 12 2025-12-16T05:00:00Z   2025-12-16T20:27:46Z   1 0 09000064b90dccd1
FDA-2007-D-0369-2419 FDA None FDA-2007-D-0369 Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availability Notice Notice of Availability 2025-12-08T05:00:00Z 2025 12 2025-12-08T05:00:00Z   2025-12-09T00:20:26Z 2025-22249 0 0 09000064b90b585d
FDA-2007-D-0369-2338 FDA None FDA-2007-D-0369 PSG_216540 - Draft Guidance on Acoramidis Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:42:47Z   1 0 09000064b90ae511
FDA-2007-D-0369-2409 FDA None FDA-2007-D-0369 PSG_215272 - Draft Guidance on Tapinarof Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:18Z   1 0 09000064b90aee6c
FDA-2007-D-0369-2392 FDA None FDA-2007-D-0369 PSG_215014 - Draft Guidance on Pegcetacoplan Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:17Z   1 0 09000064b90aee4a
FDA-2007-D-0369-2407 FDA None FDA-2007-D-0369 PSG_219209 - Draft Guidance on Suzetrigine Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:08Z   1 0 09000064b90aee68
FDA-2007-D-0369-2402 FDA None FDA-2007-D-0369 PSG_218944 - Draft Guidance on Revumenib Citrate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:43Z   1 0 09000064b90aee5e
FDA-2007-D-0369-2388 FDA None FDA-2007-D-0369 PSG_022000 - Draft Guidance on Mesalamine Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:09:56Z   1 0 09000064b90aee42
FDA-2007-D-0369-2360 FDA None FDA-2007-D-0369 PSG_020062 - Draft Guidance on Diltiazem Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:48:31Z   1 0 09000064b90aee05
FDA-2007-D-0369-2382 FDA None FDA-2007-D-0369 PSG_211913 - Draft Guidance on Isotretinoin Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:51Z   1 0 09000064b90aee34
FDA-2007-D-0369-2351 FDA None FDA-2007-D-0369 PSG_022012 - Draft Guidance on Carvedilol Phosphate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:46:04Z   1 0 09000064b90ae582
FDA-2007-D-0369-2366 FDA None FDA-2007-D-0369 PSG_214697 - Draft Guidance on Epinephrine Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:50:08Z   1 0 09000064b90aee11
FDA-2007-D-0369-2374 FDA None FDA-2007-D-0369 PSG_218230 - Draft Guidance on Gepotidacin Mesylate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:55:39Z   1 0 09000064b90aee21
FDA-2007-D-0369-2369 FDA None FDA-2007-D-0369 PSG_210132 - Draft Guidance on Estradiol; Progesterone Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:51:18Z   1 0 09000064b90aee17
FDA-2007-D-0369-2377 FDA None FDA-2007-D-0369 PSG_219141 - Draft Guidance on Hydrochlorothiazide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:10Z   1 0 09000064b90aee27
FDA-2007-D-0369-2379 FDA None FDA-2007-D-0369 PSG_214581 - Draft Guidance on Hydroxychloroquine Sulfate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:28Z   1 0 09000064b90aee2b
FDA-2007-D-0369-2344 FDA None FDA-2007-D-0369 PSG_208772 - Draft Guidance on Brigatinib Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:44:15Z   1 0 09000064b90ae576
FDA-2007-D-0369-2393 FDA None FDA-2007-D-0369 PSG_214511 - Draft Guidance on Pegulicianine Acetate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:23Z   1 0 09000064b90aee4c
FDA-2007-D-0369-2411 FDA None FDA-2007-D-0369 PSG_021318 - Draft Guidance on Teriparatide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:28Z   1 0 09000064b90aee70
FDA-2007-D-0369-2412 FDA None FDA-2007-D-0369 PSG_208088 - Draft Guidance on Testosterone Undecanoate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:33Z   1 0 09000064b90aee72
FDA-2007-D-0369-2401 FDA None FDA-2007-D-0369 PSG_009829 - Draft Guidance on Pyridostigmine Bromide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:35Z   1 0 09000064b90aee5c
FDA-2007-D-0369-2404 FDA None FDA-2007-D-0369 PSG_218160 - Draft Guidance on Selpercatinib Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:53Z   1 0 09000064b90aee62
FDA-2007-D-0369-2383 FDA None FDA-2007-D-0369 PSG_208462 - Draft Guidance on Ixazomib Citrate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:59Z   1 0 09000064b90aee38
FDA-2007-D-0369-2367 FDA None FDA-2007-D-0369 PSG_021323-ODT - Draft Guidance on Escitalopram Oxalate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:50:24Z   1 0 09000064b90aee13
FDA-2007-D-0369-2385 FDA None FDA-2007-D-0369 PSG_219132 - Draft Guidance on Levacetylleucine Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:57:14Z   1 0 09000064b90aee3c
FDA-2007-D-0369-2368 FDA None FDA-2007-D-0369 PSG_214846 - Draft Guidance on Estradiol; Norethindrone Acetate; Relugolix Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:50:41Z   1 0 09000064b90aee15
FDA-2007-D-0369-2353 FDA None FDA-2007-D-0369 PSG_212839 - Draft Guidance on Cenobamate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:46:32Z   1 0 09000064b90ae586
FDA-2007-D-0369-2343 FDA None FDA-2007-D-0369 PSG_215064 - Draft Guidance on Birch Triterpenes Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2026-02-07T13:12:43Z   1 0 09000064b90ae574
FDA-2007-D-0369-2375 FDA None FDA-2007-D-0369 PSG_212097 - Draft Guidance on Glucagon Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:55:54Z   1 0 09000064b90aee23
FDA-2007-D-0369-2362 FDA None FDA-2007-D-0369 PSG_218860 - Draft Guidance on Elafibranor Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:49:00Z   1 0 09000064b90aee09
FDA-2007-D-0369-2365 FDA None FDA-2007-D-0369 PSG_019430 - Draft Guidance on Epinephrine Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:49:53Z   1 0 09000064b90aee0f
FDA-2007-D-0369-2381 FDA None FDA-2007-D-0369 PSG_216017 - Draft Guidance on Iomeprol Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:43Z   1 0 09000064b90aee2f
FDA-2007-D-0369-2370 FDA None FDA-2007-D-0369 PSG_018922-Tab - Draft Guidance on Etodolac Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:54:41Z   1 0 09000064b90aee19
FDA-2007-D-0369-2364 FDA None FDA-2007-D-0369 PSG_218171 - Draft Guidance on Ensartinib Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:49:32Z   1 0 09000064b90aee0d
FDA-2007-D-0369-2356 FDA None FDA-2007-D-0369 PSG_202806 - Draft Guidance on Dabrafenib Mesylate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:47:14Z   1 0 09000064b90ae58c
FDA-2007-D-0369-2339 FDA None FDA-2007-D-0369 PSG_214056 - Draft Guidance on Apomorphine Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:43:17Z   1 0 09000064b90ae56c
FDA-2007-D-0369-2398 FDA None FDA-2007-D-0369 PSG_009170-ODT - Draft Guidance on Primidone Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:00Z   1 0 09000064b90aee56
FDA-2007-D-0369-2399 FDA None FDA-2007-D-0369 PSG_015193 - Draft Guidance on Pyridostigmine Bromide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:06Z   1 0 09000064b90aee58
FDA-2007-D-0369-2414 FDA None FDA-2007-D-0369 PSG_214759 - Draft Guidance on Treosulfan Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:43Z   1 0 09000064b90aee76
FDA-2007-D-0369-2397 FDA None FDA-2007-D-0369 PSG_017469 - Draft Guidance on Prednisolone Acetate Other Letter(s) 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:44Z   1 0 09000064b90aee54
FDA-2007-D-0369-2390 FDA None FDA-2007-D-0369 PSG_021636 - Draft Guidance on Omeprazole; Sodium Bicarbonate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:07Z   1 0 09000064b90aee46
FDA-2007-D-0369-2417 FDA None FDA-2007-D-0369 PSG_022103 - Draft Guidance on Trospium Chloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:13:00Z   1 0 09000064b90aee7c
FDA-2007-D-0369-2405 FDA None FDA-2007-D-0369 PSG_215256 - Draft Guidance on Semaglutide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:58Z   1 0 09000064b90aee64
FDA-2007-D-0369-2406 FDA None FDA-2007-D-0369 PSG_021938 - Draft Guidance on Sunitinib Malate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:03Z   1 0 09000064b90aee66
FDA-2007-D-0369-2408 FDA None FDA-2007-D-0369 PSG_217439 - Draft Guidance on Talazoparib Tosylate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:13Z   1 0 09000064b90aee6a
FDA-2007-D-0369-2413 FDA None FDA-2007-D-0369 PSG_215866 - Draft Guidance on Tirzepatide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:38Z   1 0 09000064b90aee74
FDA-2007-D-0369-2391 FDA None FDA-2007-D-0369 PSG_217171 - Draft Guidance on Pegcetacoplan Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:12Z   1 0 09000064b90aee48
FDA-2007-D-0369-2400 FDA None FDA-2007-D-0369 PSG_217604 - Draft Guidance on Pyridostigmine Bromide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:11:19Z   1 0 09000064b90aee5a
FDA-2007-D-0369-2389 FDA None FDA-2007-D-0369 PSG_213593 - Draft Guidance on Omeprazole; Sodium Bicarbonate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:02Z   1 0 09000064b90aee44
FDA-2007-D-0369-2387 FDA None FDA-2007-D-0369 PSG_206321 - Draft Guidance on Liraglutide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:09:51Z   1 0 09000064b90aee40
FDA-2007-D-0369-2350 FDA None FDA-2007-D-0369 PSG_022556 - Draft Guidance on Carbinoxamine Maleate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:45:51Z   1 0 09000064b90ae580
FDA-2007-D-0369-2371 FDA None FDA-2007-D-0369 PSG_212102 - Draft Guidance on Fenfluramine Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:54:52Z   1 0 09000064b90aee1b
FDA-2007-D-0369-2361 FDA None FDA-2007-D-0369 PSG_218711 - Draft Guidance on Docetaxel Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:48:45Z   1 0 09000064b90aee07
FDA-2007-D-0369-2376 FDA None FDA-2007-D-0369 PSG_210134 - Draft Guidance on Glucagon Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:03Z   1 0 09000064b90aee25
FDA-2007-D-0369-2357 FDA None FDA-2007-D-0369 PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:47:34Z   1 0 09000064b90ae58e
FDA-2007-D-0369-2340 FDA None FDA-2007-D-0369 PSG_214927 - Draft Guidance on Arimoclomol Citrate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:43:26Z   1 0 09000064b90ae56e
FDA-2007-D-0369-2345 FDA None FDA-2007-D-0369 PSG_215935 - Draft Guidance on Budesonide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:44:28Z   1 0 09000064b90ae578
FDA-2007-D-0369-2418 FDA None FDA-2007-D-0369 PSG_214938 - Draft Guidance on Vosoritide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-08T10:00:23Z   1 0 09000064b90aee7e
FDA-2007-D-0369-2359 FDA None FDA-2007-D-0369 PSG_218730 - Draft Guidance on Deutivacaftor; Tezacaftor; Vanzacaftor Calcium Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:48:17Z   1 0 09000064b90aee03
FDA-2007-D-0369-2373 FDA None FDA-2007-D-0369 PSG_020121 - Draft Guidance on Fluticasone Propionate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:55:30Z   1 0 09000064b90aee1f
FDA-2007-D-0369-2358 FDA None FDA-2007-D-0369 PSG_017922 - Draft Guidance on Desmopressin Acetate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:47:49Z   1 0 09000064b90ae590
FDA-2007-D-0369-2384 FDA None FDA-2007-D-0369 PSG_205388 - Draft Guidance on Ketorolac Tromethamine; Phenylephrine Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:57:07Z   1 0 09000064b90aee3a
FDA-2007-D-0369-2352 FDA None FDA-2007-D-0369 PSG_216165 - Draft Guidance on Cefepime Hydrochloride; Enmetazobactam Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:46:18Z   1 0 09000064b90ae584
FDA-2007-D-0369-2380 FDA None FDA-2007-D-0369 PSG_216016 - Draft Guidance on Iomeprol Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:36Z   1 0 09000064b90aee2d
FDA-2007-D-0369-2363 FDA None FDA-2007-D-0369 PSG_217660 - Draft Guidance on Elexacaftor, Ivacaftor, Tezacaftor; Ivacaftor Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:49:16Z   1 0 09000064b90aee0b
FDA-2007-D-0369-2372 FDA None FDA-2007-D-0369 PSG_215168 - Draft Guidance on Flurpiridaz F-18 Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:55:21Z   1 0 09000064b90aee1d
FDA-2007-D-0369-2342 FDA None FDA-2007-D-0369 PSG_207924 - Draft Guidance on Baricitinib Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:43:47Z   1 0 09000064b90ae572
FDA-2007-D-0369-2347 FDA None FDA-2007-D-0369 PSG_215430 - Draft Guidance on Bupropion Hydrochloride; Dextromethorphan Hydrobromide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:44:56Z   1 0 09000064b90ae57c
FDA-2007-D-0369-2341 FDA None FDA-2007-D-0369 PSG_017851 - Draft Guidance on Baclofen Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:43:37Z   1 0 09000064b90ae570
FDA-2007-D-0369-2410 FDA None FDA-2007-D-0369 PSG_213931 - Draft Guidance on Tenapanor Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:23Z   1 0 09000064b90aee6e
FDA-2007-D-0369-2395 FDA None FDA-2007-D-0369 PSG_214770 - Draft Guidance on Poscaconazole Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:33Z   1 0 09000064b90aee50
FDA-2007-D-0369-2403 FDA None FDA-2007-D-0369 PSG_217242 - Draft Guidance on Roflumilast Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-23T10:00:12Z   1 0 09000064b90aee60
FDA-2007-D-0369-2415 FDA None FDA-2007-D-0369 PSG_214324 - Draft Guidance on Treprostinil Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:48Z   1 0 09000064b90aee78
FDA-2007-D-0369-2386 FDA None FDA-2007-D-0369 PSG_022341 - Draft Guidance on Liraglutide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:09:46Z   1 0 09000064b90aee3e
FDA-2007-D-0369-2396 FDA None FDA-2007-D-0369 PSG_019561 - Draft Guidance on Potassium chloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:38Z   1 0 09000064b90aee52
FDA-2007-D-0369-2416 FDA None FDA-2007-D-0369 PSG_017340 - Draft Guidance on Tretinoin Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:12:53Z   1 0 09000064b90aee7a
FDA-2007-D-0369-2394 FDA None FDA-2007-D-0369 PSG_216483 - Draft Guidance on Pivmecillinam Hydrochloride Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T23:10:28Z   1 0 09000064b90aee4e
FDA-2007-D-0369-2349 FDA None FDA-2007-D-0369 PSG_017769 - Draft Guidance on Calcitonin Salmon Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:45:35Z   1 0 09000064b90af592
FDA-2007-D-0369-2378 FDA None FDA-2007-D-0369 PSG_018303 - Draft Guidance on Hydrochlorothiazide; Metoprolol Tartrate Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:56:19Z   1 0 09000064b90aee29
FDA-2007-D-0369-2354 FDA None FDA-2007-D-0369 PSG_218808 - Draft Guidance on Crinecerfont Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:46:46Z   1 0 09000064b90ae588
FDA-2007-D-0369-2348 FDA None FDA-2007-D-0369 PSG_020664 - Draft Guidance on Cabergoline Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:45:11Z   1 0 09000064b90ae57e
FDA-2007-D-0369-2355 FDA None FDA-2007-D-0369 PSG_218820 - Draft Guidance on Crinecerfont Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:46:59Z   1 0 09000064b90ae58a
FDA-2007-D-0369-2346 FDA None FDA-2007-D-0369 PSG_020929 - Draft Guidance on Budesonide Other Guidance 2025-12-05T05:00:00Z 2025 12 2025-12-05T05:00:00Z 2026-02-04T04:59:59Z 2025-12-05T20:44:46Z   1 0 09000064b90ae57a
FDA-2007-D-0369-2337 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2025-12-05T05:00:00Z 2025 12     2025-12-05T19:22:56Z 2025-22131 0 0 09000064b90b00b7
FDA-2007-D-0369-2297 FDA None FDA-2007-D-0369 PSG_022383 - Draft Guidance on Indacaterol Maleate Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:09:40Z   1 0 09000064b908bac8
FDA-2007-D-0369-2272 FDA None FDA-2007-D-0369 PSG_021658 - Draft Guidance on Ciclesonide Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:07:23Z   1 0 09000064b908c9be
FDA-2007-D-0369-2281 FDA None FDA-2007-D-0369 PSG_207534 - Draft Guidance on Epinephrine Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:08:11Z   1 0 09000064b908baa8
FDA-2007-D-0369-2325 FDA None FDA-2007-D-0369 PSG_218010 - Draft Guidance on Travoprost Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:12:07Z   1 0 09000064b908ca20
FDA-2007-D-0369-2264 FDA None FDA-2007-D-0369 PSG_217424 - Draft Guidance on Berdazimer Sodium Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:06:35Z   1 0 09000064b908c9ae
FDA-2007-D-0369-2329 FDA None FDA-2007-D-0369 PSG_209241 - Draft Guidance on Valbenazine Tosylate Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:12:31Z   1 0 09000064b908ca28
FDA-2007-D-0369-2285 FDA None FDA-2007-D-0369 PSG_210589 - Draft Guidance on Fish Oil Triglycerides Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:08:35Z   1 0 09000064b908bab0
FDA-2007-D-0369-2301 FDA None FDA-2007-D-0369 PSG_204410 - Draft Guidance on Draft Guidance on Macitentan Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:10:01Z   1 0 09000064b908bad0
FDA-2007-D-0369-2276 FDA None FDA-2007-D-0369 PSG_216099 - Draft Guidance on Dasatinib Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:07:45Z   1 0 09000064b908ba9e
FDA-2007-D-0369-2290 FDA None FDA-2007-D-0369 PSG_210828 - Draft Guidance on Gallium GA 68 Edotreotide Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:09:02Z   1 0 09000064b908baba
FDA-2007-D-0369-2310 FDA None FDA-2007-D-0369 PSG_208051 - Draft Guidance on Neratinib Maleate Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:10:48Z   1 0 09000064b908ca02
FDA-2007-D-0369-2326 FDA None FDA-2007-D-0369 PSG_216158 - Draft Guidance on Trospium Chloride; Xanomeline Tartrate Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:12:13Z   1 0 09000064b908ca22
FDA-2007-D-0369-2312 FDA None FDA-2007-D-0369 PSG_204508 - Draft Guidance on Olive Oil; Soybean Oil Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:10:58Z   1 0 09000064b908ca06
FDA-2007-D-0369-2273 FDA None FDA-2007-D-0369 PSG_213227 - Draft Guidance on Copper CU-64 Dotatate Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:07:28Z   1 0 09000064b908c9c0
FDA-2007-D-0369-2304 FDA None FDA-2007-D-0369 PSG_216755 - Draft Guidance on Metronidazole Other Guidance 2025-11-21T05:00:00Z 2025 11 2025-11-21T05:00:00Z 2026-01-21T04:59:59Z 2025-11-21T20:10:18Z   1 0 09000064b908c9d8

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 2407.34ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API